Evidence map›Paper›PMID 21400122›Full record

ArticleInflammation2012

The burn wound inflammatory response is influenced by midazolam.

George F Babcock, Laura Hernandez, Ekta Yadav, Sandy Schwemberger, Amy Dugan

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Sleep Immune Cross Talk and Insomnia.Advances in experimental medicine and biology · 2023
    Review
  3. Midazolam's Effects on Delayed-Rectifier KInternational journal of molecular sciences · 2021
    Article
  4. Associations between anxiolytic medications and ventral hernia repair.Hernia : the journal of hernias and abdominal wall surgery · 2018
    Article
  5. Review
  6. Article
  7. The extracellular matrix protein matrilin-2 induces post-burn inflammatory responses as an endogenous danger signal.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

George F BabcockDepartment of Research, Shriners Hospital Cincinnati, University of Cincinnati, 3229 Burnet Avenue, Cincinnati, OH 45229, USA.
Laura Hernandez
Ekta Yadav
Sandy Schwemberger
Amy Dugan
University of Cincinnati · USShriners Hospitals for Children - Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Burn patients requiring hospitalization are often treated for anxiety with benzodiazepines (BDZs). Benzodiazepines are reported to influence immune system function. Immune system alterations are a major cause of burn-induced mortality. We wanted to determine whether the BDZ, midazolam given daily at an anxiolytic dose, had any influence on the burn injury-induced inflammatory response in the blood and wound. Mice received a 15% total body surface area flame burn and received either midazolam 1 mg/kg i.p. or saline 0.1 ml daily. Blood and skin wounds were harvested 24 h after injection on post-burn day 2, 3, 7, or 8. Mice treated with midazolam had significantly lower serum IL-1β (p=0.002), TNF-α (p=0.002), IL-6 (p=0.016), IL-10 (p=0.009), and TGF-β (p=0.004) than saline-treated mice, with little impact on serum chemokine levels. In the wound, TNF-α and IL-10 were the only cytokines significantly influenced by the drug, being lower (p=0.018) and higher (p=0.006), respectively. The chemokines in the wound influenced significantly by midazolam were MIP-1α, MIP-1β, and MIP-2 while MCP-1 and KC were not. There were more inflammatory cells at the burn wound margin in midazolam-treated mice on post-burn day 3. Although serum nitrate/nitrite was significantly increased by midazolam (p=0.03), both eNOS and iNOS mRNA expression in the wound were similar to the saline group. We found that midazolam given daily after burn injury significantly influenced the inflammatory response. The clinical implications of these findings on wound healing and shock following burn injury, especially larger burns, deserve further investigation.

Indexed as

AnimalsBurnsChemokine CCL2Chemokine CCL3Chemokine CCL4Chemokine CXCL2InflammationInterleukin-10Interleukin-1betaInterleukin-6MaleMiceMice, Inbred C57BLMidazolamNitric Oxide Synthase Type IINitric Oxide Synthase Type IIICcl2 protein, mouseChemokine CCL2Chemokine CCL3Chemokine CCL4Chemokine CXCL2Interleukin-10Interleukin-1betaInterleukin-6MidazolamNitric Oxide Synthase Type IINitric Oxide Synthase Type IIIRNA, MessengerTransforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID21400122
OpenAlexW2148874822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.